Member Info for bignose58

? should have been something else

¯\_(~_~)_/¯

¯\_(?)_/¯

The.Italian.

I am sure they will hold. DL will need money and I am sure Fortacin will be used to pay for it. We all invested in Fortacin and know its potential (even if let down by a bunch of monkeys and clowns). Its just taken longer to come to fruition because of it, however. Once the we reach phase III, a US license is agreed, which I am sure will provoke the remaining licensees to climb on board, there is still huge potential, which is what I signed up for in the first place.

As stated before. JM only invests his pocket money and as long as I have been invested he has never made any PI any money in the companies I know of, although he just loves all the attention. All the others who work for him are just his puppets, some are well paid puppets, but puppets never the less. Although I cannot help but feel for Dr Mike since once we reach the US conclusion, his job will be done as its quite obvious he does not figure in the companies future otherwise there would be more about him in the announcements. Mind you, he probably is looking forward to spending quality time with his wife and family.

Anyway, roll on the OTC launch and US approval (not sure if China will bare any fruit as its already taken 2 years since the agreement and we have not even started any testing yet. By the time we get any approval, the formulation will have been leaked, stolen and every dogs body in China will be producing some concoction of our product).

The.Italian,

Read these and make your own mind up about how incestuous it all is.

Juvenescence Ltd., which has raised $62.5 million from Mellon and some partners, has invested in or is close to confirming investments in nine biotech companies. He won’t discuss most of them. But one of the deals was an 11 percent stake in Insilico Medicine, a company applying machine-learning techniques to drug discovery. Insilico Medicine and Mellon’s company also formed a joint venture called Juvenescence AI to investigate the therapeutic properties of specific compounds.

https://medium.com/neodotlife/juvenescence-jim-mellon-longevity-e9a415dd0569

https://www.fiercebiotech.com/biotech/new-insilico-medicine-spin-out-to-tackle-longevity-covid

Lets hope it does (this time) eventually lead to some desperately needed income.

The.Italiaan.

Although not read before. I wouldn't be surprised if JM was not on the list of undisclosed celebrity investors in the initial investment round since he is to be the chairman like the majority of his investments...... Quite interesting timeline don't you think. DLI spun off, then suddenly purchased by Regent. Obviously RPG were very lucky to be in the right place at the right time....LOL

“Other undisclosed investors include celebrity investors in artificial intelligence and some of the most prominent U.S. biotechnology investors,” it added, but again with no details.

Yup,

I'm getting my I's n L's mixed up... should be DLI, although easily done when ones never heard of them before....lol

Yeah, you are probably right Dougie.

http://www.regentpac.com/ICMServlet/download/13-2361-3828/EAnnt-OperationsUnpdate(03Sep2020).pdf

Yes, of course you are indeed right. But I was thinking that after all these years and JG being a so called lawyer (I use the word lightly) they would not be playing these games, which as you know “entering the CBD market” and “our other Pharma investment” are/were crossing the line (Parasites come to mind). Anyroadup, As you wrote. Leopards and all that....

Good luck with your research. I’ll do a bit of my own too although, I’m not sure if I’ll find anything on a non entity :-)

It may have been left field to us nobodies, but certainly not left field to the minority who gain from it.

Happy reading.

The.Italian,

Although no expert, it seems quite obvious to me that the local brokers were using this to make a **** load of money. One only has to look at the majority of the size of the singe trades. RPG know this from past history pre and post PLE, hence they used it to their advantage. The convenient price drop, making a deal at nearly the low, then (probably indirectly) leaking the DLI news to lift it. Once they were aware Recordati had received the approval (which I understand was a given after the positive CHMP announcement) they then made the DLI announcement with the EU OTC approval announcement the day after. (7 days after the approval). It all stinks to me.

Not that I am unhappy to see the rise as its back nearer to a reasonable value, however. I will be very surprised if its sustainable due to local traders selling out unless we get something more substantial.

I'm at two mind with respect to the DIL deal since at this moment in time I cannot see how they will add value to the company without a business strategy...How are they to be funded in the short term? What companies are they targeting. We need more details than just company speculation which, as you know, has let us down quite miserably before.

All the above is just my opinion, but the dots do seem to join up.... ;-)

I use the above to check volumes and price. Currently the transactions page indicates 561 mill volume, yet the quick and detailed quote pages are indicating 572mill shares. Has anyone else noticed that...is it a bug ?

Will be interesting to see how long it lasts since Futu Sec is a local (Shanghai, HK registered online) broker and although they were "all over this" being online I would suspect most of the traders probably have no idea about the company. They see a megga rise and jump on hoping to make their 20%. All ok if you are a trader and wanting a quick buck, but probably not so clever if you have invested for the long term. RPG needs to get that US license agreement in place to attract the institutions which will keep the price at a more stable and sustainable level.

Anyway, fingers crossed the company is now turned the corner and its true value will be realised. Who knows, we may even get a divi next year, if a US upfront payment is exceptional........... one can but dream...LOL

Anyone any ideas how DIL will be adding value to the company ? They have AI but who will they be selling it to and what would be an expected income ?

So at lunchtime closing SP = 0.198 (up 76.8%)

Peaked at about 11:32 SP = 0.238 (up 112.5% and DIL at this price would cost us 13.46mill USD which is only 9.17mill more than the recommended market price....cough..... A funny old world isn't it....... :-)

I'm sure it has, we just need news on the US license front and were off to the races, however. if there is no news on a License agreement, this will start to drift down again.

What is needed are some major institutional investors to create stability and confidence. Unfortunately and I could be wrong, but I'm pretty sure they will not show any interest before a US license agreement and if that's not forthcoming, they will want to see some pretty positive EU sales figures to back up their investment..... Once bitten twice shy and all that.

Well...... up 45+% on opening, dropping back a little within a few minutes. Seems this was certainly a game plan. and although RPG stated the deal got DIL 500K USD cheaper (Hoorahh), seems like we may be paying more than double for it once signed....

Lets see how the day plays out once the sellers start piling in.

Yes, it is good news, although it remains to be seen if the OTC significantly increases sales as stated, however. That was last Thursday. why have they only released the news today....a week later ???

Hopefully the news will abate the sell off and may even push the price higher (was that the plan ?)

Also, I'm somewhat confused as to why they discuss the upscaling to 50k cans since they already went through this process two years ago, whcich was approved by the EU. At teh same time PSNW even purchased another production line which I understood would take a year or so to install so there surely will be no issue in 50k batch production even with other orders. JG even gave me the breakdown in hours of how long it takes to produce a batch.... see below, which was received around June 2018.

The time frame for manufacturing each batch size of 50,000 units is.....
Clean, Manufacture & Fill = 76hrs
Quarantine = 14 days
FP Testing = 40hrs
Packing = 48 hrs
QA/QP review and release = 40 hrs

Note that this assumes that PSNW has in stock the API and all raw materials valves and cans etc are available.

"PSNW has recently bought another line with a capacity of an additional 8m annual capacity which they are looking to install next year. With this in mind capacity, isn't likely to be a constraint in the near future".

It will be interesting to see what impact this news has on the market tomorrow. Also will Recordati be launching the other two regions in Jan 2020 at the same time (they were due to be launched this time last year, then this time this year...maybe Jan next year ?

It does smack a little of a desperation rebound given all the talk had been about CBD, which now seems to have disappeared, even with the concrete. The other thing I notice is no mention of the combined company with ref to Fortacin which makes me wonder if they are looking to offload that asap particularly since JM appears to have lost interest in that money dribble route.

I wonder if Fortacin was discussed with all the involved shareholders hence the low ball offer with the prospect of a good return in a few months ?

Just musing over things.

Sorry about that. My computer started playing up and it looked like I'd lost the post so I posted again. I wonder if DLI can help me remember what Id just written, if it happens again...... :-)

I guess we should feel lucky since.......

Accordingly, the professional independent valuation of DLI of US$4.30 million (or approximately
HK$33.54 million) set out in the independent valuation report is in excess of the total consideration by approximately US$0.51 million (or approximately HK$3.98 million) agreed among the parties pursuant to the Share Purchase Agreements.

I wonder if that is the same professional company that was involved in advising on the US can size......GULP

I guess we should feel lucky since....

As referred to above, as part of its due diligence on DLI, the Company commissioned a
professional independent valuation to be conducted on DLI and its business. The Company is
pleased to report that the professional independent valuation concluded that the fair value of the equity of DLI is US$4.30 million (or approximately HK$33.54 million), which is in excess of the total consideration that the Company has agreed to pay the Sellers.

I wonder if that was the same professional company that got involved in the can sizing for the US ....... GULP.... :-(